Home > Boards > US Listed > Medical - Equipment > Thoratec Corporation (THOR)

Catalyst behind Thoratec spike higher unclear

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
abbey1212 Member Profile
 
Followed By 9
Posts 179
Boards Moderated 0
Alias Born 02/10/14
160x600 placeholder
Quarterly Report (10-q) Edgar (US Regulatory) - 8/1/2019 4:46:27 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/1/2019 4:18:15 PM
Synthorx Reports Second Quarter Financial Results GlobeNewswire Inc. - 8/1/2019 4:05:00 PM
Synthorx Initiates Patient Dosing in Australia and Announces Clearance of IND in the U.S. for Lead Immuno-oncology Product Ca... GlobeNewswire Inc. - 7/24/2019 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/20/2019 4:07:22 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/11/2019 4:32:33 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/10/2019 6:56:55 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/10/2019 6:55:19 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/10/2019 6:53:19 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/10/2019 6:47:57 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/10/2019 6:43:52 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/10/2019 6:38:41 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/10/2019 4:01:59 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/31/2019 4:09:11 PM
Synthorx to Present at Jefferies 2019 Healthcare Conference GlobeNewswire Inc. - 5/29/2019 4:10:00 PM
Synthorx to Present at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting GlobeNewswire Inc. - 5/15/2019 5:15:00 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 4/30/2019 4:46:48 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/30/2019 4:28:31 PM
Synthorx Reports First Quarter Financial Results GlobeNewswire Inc. - 4/30/2019 4:05:00 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 4/24/2019 5:21:55 PM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 4/24/2019 4:35:23 PM
Synthorx to Present at H.C. Wainwright Global Life Sciences Conference in London GlobeNewswire Inc. - 4/2/2019 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/2/2019 7:47:04 AM
Synthorx to Present at the American Association of Cancer Research (AACR) Annual Meeting 2019 GlobeNewswire Inc. - 3/19/2019 8:00:00 AM
Annual Report (10-k) Edgar (US Regulatory) - 3/12/2019 4:38:32 PM
abbey1212   Tuesday, 07/21/15 11:12:03 AM
Re: None
Post # of 22 
Catalyst behind Thoratec spike higher unclear

The catalyst behind the spike higher in shares of Thoratec (THOR) is unclear to traders and investors. The medical device maker focused on advanced heart failure patients rose as high $62.05 in early trading and its shares remain up 11%, or $5.48, to $54.29. Some vague takeover chatter surfaced, with St. Jude Medical (STJ) as the speculated buyer, but buyout rumors are often the "go-to" reason when stocks spike. Often the moves on rumors are less substantial than Thoratec's spike today. The company's close competitor HeartWare (HTWR) is not seeing any unusual trading thus far today, falling 36c to $78.81 in early trading.


Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist